Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Automation
Return to: PBR Home | Automation
Today in Automation

Automation

Seres' SER-109 gets FDA breakthrough therapy status to prevent CDI in adults Seres Therapeutics has received breakthrough therapy designation from the US Food and Drug Administration (FDA) for its lead product candidate SER-109 (Firmacute Eubacterial Spores, Purified Suspension, Encapsulated), being evaluated to prevent recurrent Clostridium difficile infection (CDI) in adults. Automation > IT & Software > News

Latest Automation News by Sector

Select a sector from the list or browse by sector below:

IT & Software

BSN medical expand lymphoedema therapy solutions with FarrowMed acquisition
BSN medical continues to strengthen its position as a market leading provider of lymphoedema therapy solutions by acquiring FarrowMed and its range of patented FarrowWrap and related compression garment technologies, which focus on the management of lymphoedema and venous disease.
Automation > IT & Software > News
SteadyMed, Cardiome partner to commercialize PAH drug Trevyent outside US
By PBR Staff Writer
US pharmaceutical firm SteadyMed has entered into an exclusive license and supply agreement with Canada-based Cardiome to commercialize Trevyent in certain regions outside the US if the drug is approved to treat pulmonary arterial hypertension (PAH), in such regions.
Automation > IT & Software > News

Laboratory Instrumentation

Cepheid, pharma firms collaborate on diagnostic test for multidrug-resistant bacterial infections
By PBR Staff Writer
Cepheid has entered into a new collaboration with AstraZeneca, Cubist and GSK to encourage transformational change in infectious disease therapy.
Automation > Laboratory Instrumentation > News
BioLight announces start of clinical study with DiagnosTear dry eye syndrome diagnostic assay
BioLight Life Sciences Investments announced that DiagnosTear has received all necessary approvals from Sheba Medical Center near Tel Aviv to begin a clinical study with its TeaRx, point-of-care Dry Eye Syndrome diagnostic assay. DiagnosTear is part of BioLight’s XLVision Sciences ophthalmology cluster.
Automation > Laboratory Instrumentation > News